CN Stock MarketDetailed Quotes

603520 Zhejiang Starry Pharmaceutical

Watchlist
  • 12.38
  • +0.51+4.30%
Market Closed Apr 29 15:00 CST
4.24BMarket Cap90.36P/E (TTM)

Zhejiang Starry Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Starry Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

642.30M

+13.50%
EPS(YoY)

0.04

+33.33%
Analyst Rating

Strong Buy

Apr 29, 2024

Zhejiang Starry Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/FY-- / 2.912B--
--2023/FY-- / 2.437B--
--2022/FY2.131B / 2.078B--
--2021/FY2.000B / 1.950B--
--2020/FY1.367B / 1.668B--
Mar 31, 20202019/FY1.309B / 1.344B--
DatePeriodRevenue/EstimateEarnings Call
--2024/FY-- / 2.912B--
--2023/FY-- / 2.437B--
--2022/FY2.131B / 2.078B--
--2021/FY2.000B / 1.950B--
--2020/FY1.367B / 1.668B--
Mar 31, 20202019/FY1.309B / 1.344B--
--------
--------
--------
--------

Unlock Free Earnings Estimates

Zhejiang Starry Pharmaceutical Earnings Reports

  • Stelli's 2023 Annual Report (full text)

    just now

  • Stelli's report for the first quarter of 2024

    just now

  • Summary of the 2023 Annual Report of Zhejiang Stary Pharmaceutical Co., Ltd.

    just now

  • Starry\'s 2023 Annual Results Forecast

    Jan 30 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 29, 2024

    Strong Buy

    • Strong Buy

      75.00%

    • Buy

      25.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg